NASDAQ: USCTRoth Ch Acquisition Co Stock
$9.86-1.38 (-12.28%)
Updated Apr 24, 2024
USCT Price
$9.86
Fair Value Price
$0.02
Market Cap
$77.59M
52 Week Low
$9.86
52 Week High
$11.38
P/E
42.87x
P/B
-41.99x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.59M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.03
Operating Cash Flow
-$863k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
USCT Overview
TKB Critical Technologies 1 is a special purpose acquisition company (SPAC) formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar combinations with one or more businesses. The company targets the tech, data security, energy storage and power management, fintech, microelectronics, robotics, and wireless communications equipment sectors. TKB Critical Technologies 1 was incorporated in 2021 and is headquartered in El Segundo, CA.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how USCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
USCT ($9.86) is overvalued by 45,534.55% relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
USCT ($9.86) is not significantly undervalued (45,534.55%) relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
USCT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more USCT due diligence checks available for Premium users.
Be the first to know about important USCT news, forecast changes, insider trades & much more!
USCT News
Valuation
USCT fair value
Fair Value of USCT stock based on Discounted Cash Flow (DCF)
Price
$9.86
Fair Value
$0.02
Overvalued by
45,534.55%
USCT ($9.86) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
USCT ($9.86) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
USCT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
USCT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.87x
Industry
35.99x
Market
41.27x
USCT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
USCT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
USCT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-41.99x
Industry
-14.41x
USCT's financial health
Profit margin
Revenue
$0.0
Net Income
$1.2M
Profit Margin
0%
USCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$23.5M
Liabilities
$1.9M
Debt to equity
-1.03
USCT's short-term liabilities ($1.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
USCT's long-term liabilities ($556.25k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
USCT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
USCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$198.3k
Investing
-$180.0k
Financing
$300.6k
USCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
USCT vs Shell Company Stocks
Roth Ch Acquisition Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.